[Elsevier] Part II: The treatment of primary and secondary Raynaud's phenomenon |
Reward10points
Best Answer
2024-5-4
|
| |
10
Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: A retrospective study
10
Fabrication of novel bone substitute alginate ¨C N,O-carboxymethyl chitosan ¨C Aldehyde hyaluronic acid ¨C Biphasic calcium phosphate for bone regeneration
10
Role of systemic minoxidil in the treatment of alopecia areata: A scoping review to direct future research
10
Response to ¡°Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: A retrospective study¡±
10
Investigation of oral finasteride enhanced occipital hair diameter index in different types of male androgenetic alopecia
